NCT00329160 - Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease | Biotech Hunter

Enrollment

214

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions

Hypercholesteremia

Interventions

DRUG

Rosuvastatin

2.5-20 mg

DRUG

HMG CoA inhibitor

3-hydroxy-3-methylglutaryl-coenzyme A

Trial Locations (27)

Research Site, Gifu

Research Site, Hamada

Research Site, Hiroshima

Research Site, Ichinomiya

Research Site, Inba-mura

Research Site, Izumi

Research Site, Izumisano

Research Site, Izumo

Research Site, Kagoshima

Research Site, Kanazawa

Research Site, Kasuga

Research Site, Kobe

Research Site, Komaki

Research Site, Konancho

Research Site, Kumamoto

Research Site, Kurume

Research Site, Kyoto

Research Site, Osaka

Research Site, Ōmiya

Research Site, Sapporo

Research Site, Shinjō

Research Site, Shūnan

Research Site, Suita

Research Site, Tokyo

Research Site, Ube

Research Site, Yamaguchi

Research Site, Yokohama